Abstract
Aim
To investigate the association of alleles of the 3′ immunoglobulin heavy-chain regulatory region 1 (3′RR-1) enhancer hs1.2 in patients with type 1 diabetes (T1D).
Methods
Eighty-one patients with T1D [among which 12 had concomitant coeliac disease (CD) and 25 an autoimmune thyroid disease (AITD)] were compared to 248 healthy individuals. All subjects were recruited from the same geographical area. Blood samples were collected from all patients and a nested PCR was performed to amplify the core of the 3′RR-1 and detect the alleles of the hs1.2 enhancer.
Results
Allele distribution in healthy individuals was significantly different when compared to that of patients with T1D (p < 0.01). Even greater differences were detected comparing allele distribution of patients with T1D alone versus those with concomitant CD, but not versus those with concomitant AITD. The frequency of *2 allele is increased by 23% in patients with T1D and CD.
Conclusions
The present study establishes that the multiallelic hs1.2 enhancer of the 3′RR-1 is associated with T1D, with higher frequency when there is co-occurrence of CD. This evidence has been previously observed in other immune diseases.
Similar content being viewed by others
References
Melchers F (2015) Checkpoints that control B cell development. J Clin Investig 125:2203–2210
Chatterjee S, Ju Z, Hassan R, Volpi SA, Emelyanov AV, Birshtein BK (2011) Dynamic changes in binding of immunoglobulin heavy chain 3′ regulatory region to protein factors during class switching. J Biol Chem 286:29303–29312
Kim EC, Edmonston CR, Wu X, Schaffer A, Casali P (2004) The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3′ hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem 279:42258–42269
Birshtein BK (2014) Epigenetic regulation of individual modules of the immunoglobulin heavy chain locus 3′ regulatory region. Front Immunol 5:163
Choi NM, Feeney AJ (2014) CTCF and ncRNA regulate the three-dimensional structure of antigen receptor loci to facilitate V(D)J recombination. Front Immunol 5:49
Tang SJ (2016) The R-Operon: a model of repetitive DNA-organized transcriptional compartmentation of eukaryotic chromosomes for coordinated gene expression. Genes 7:16
D’Addabbo P, Scascitelli M, Giambra V, Rocchi M, Frezza D (2011) Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3′ regulatory region. BMC Evol Biol 11:71
Mills FC, Harindranath N, Mitchell M, Max EE (1997) Enhancer complexes located downstream of both human immunoglobulin Cα genes. J Exp Med 186:845–858
Giambra V, Fruscalzo A, Giufre M et al (2005) Evolution of human IgH3′EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor’s consensus sites. Gene 346:105–114
Birshtein BK, Chen C, Saleque S, Michaelson JS, Singh M, Little RD (1997) Murine and human 3′IgH regulatory sequences. Curr Top Microbiol Immunol 224:73–80
Garot A, Marquet M, Saintamand A et al (2016) Sequential activation and distinct functions for distal and proximal modules within the IgH 3′ regulatory region. Proc Natl Acad Sci USA 113:1618–1623
Le Noir S, Laffleur B, Carrion C et al (2017) The IgH locus 3′ cis-regulatory super-enhancer co-opts AID for allelic transvection. Oncotarget 8:12929–12940
Hewitt SL, Yin B, Ji Y et al (2009) RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nat Immunol 10:655–664
Holwerda SJ, van de Werken HJ, Ribeiro de Almeida C et al (2013) Allelic exclusion of the immunoglobulin heavy chain locus is independent of its nuclear localization in mature B cells. Nucleic Acids Res 41:6905–6916
Sette M, D’Addabbo P, Kelly G et al (2016) Evidence for a quadruplex structure in the polymorphic hs1.2 enhancer of the immunoglobulin heavy chain 3′ regulatory regions and its conservation in mammals. Biopolymers 105:768–778
Serone E, Daleno C, Principi N et al (2014) The change in Ig regulation from children to adults disconnects the correlation with the 3′RR hs1.2 polymorphism. BMC Immunol 15:45
Frezza D, Giambra V, Cianci R et al (2004) Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol 39:1083–1087
Frezza D, Giambra V, Tolusso B et al (2007) Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 66:1210–1215
Frezza D, Tolusso B, Giambra V et al (2012) Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Ann Rheum Dis 71:1309–1315
Cianci R, Giambra V, Mattioli C et al (2008) Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol 128:1920–1924
Giambra V, Cianci R, Lolli S et al (2009) Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol 183:8280–8285
Aupetit C, Drouet M, Pinaud E et al (2000) Alleles of the α1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int 58:966–971
Bessette B, Guglielmi L, Cogne M, Denizot Y (2003) Nuclear factors, hs1,2 enhancer and IgA nephropathy. Kidney Int 63:767
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82
Wang Z, Xie Z, Lu Q, Chang C, Zhou Z (2017) Beyond genetics: what causes type 1 diabetes. Clin Rev Allergy Immunol 52:273–286
Pociot F, Lernmark A (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339
Crone J, Rami B, Huber WD, Granditsch G, Schober E (2003) Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 37:67–71
Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME (2014) Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Diabet Med 31:126–135
Tolusso B, Frezza D, Mattioli C et al (2009) Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 68:416–419
Liu J, Law RA, Koles PG, Saxe JC, Bottomley M, Sulentic CEW (2017) Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy. Dig Liver Dis 49:887–892
Le Noir S, Boyer F, Lecardeur S et al (2017) Functional anatomy of the immunoglobulin heavy chain 3 super-enhancer needs not only core enhancer elements but also their unique DNA context. Nucleic Acids Res 45:5829–5837
Adlercreutz EH, Svensson J, Hansen D et al (2015) Prevalence of celiac disease autoimmunity in children with type 1 diabetes: regional variations across the Oresund strait between Denmark and southernmost Sweden. Pediatr Diabetes 16:504–509
Nistico L, Fagnani C, Coto I et al (2006) Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55:803–808
Generali E, Ceribelli A, Stazi MA, Selmi C (2017) Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun 83:51–61
Funding
This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was performed according to the ethical principles of the Helsinki Declaration of 1964, revised by the World Medical Organization in Edinburgh in 2000 and 2008 and was approved by the ethics committee of our hospital.
Informed consent
All participants provided written informed consent before the enrollment in the study.
Additional information
Managed by Massimo Porta.
Rights and permissions
About this article
Cite this article
Cianci, R., D’Addabbo, P., Gambassi, G. et al. Association between IgH enhancer hs1.2 and type 1 diabetes. Acta Diabetol 55, 443–448 (2018). https://doi.org/10.1007/s00592-018-1103-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-018-1103-5